CURE.CN
Biocure Technology Inc
Price:  
0.03 
CAD
Volume:  
15,830.00
Canada | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CURE.CN WACC - Weighted Average Cost of Capital

The WACC of Biocure Technology Inc (CURE.CN) is 7.8%.

The Cost of Equity of Biocure Technology Inc (CURE.CN) is 8.30%.
The Cost of Debt of Biocure Technology Inc (CURE.CN) is 5.00%.

Range Selected
Cost of equity 6.50% - 10.10% 8.30%
Tax rate 25.90% - 26.50% 26.20%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.2% - 9.3% 7.8%
WACC

CURE.CN WACC calculation

Category Low High
Long-term bond rate 3.2% 3.7%
Equity market risk premium 5.1% 6.1%
Adjusted beta 0.66 0.97
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.50% 10.10%
Tax rate 25.90% 26.50%
Debt/Equity ratio 0.13 0.13
Cost of debt 5.00% 5.00%
After-tax WACC 6.2% 9.3%
Selected WACC 7.8%